Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer.

Angeliki Andrikopoulou,Michalis Liontos,Efthymia Skafida,Konstantinos Koutsoukos,Kleoniki Apostolidou,Maria Kaparelou,Angeliki Rouvalis,Garyfallia Bletsa,Meletios-Athanasios Dimopoulos,Flora Zagouri

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society（2023）

引用 0|浏览6

暂无评分

摘要

We showed that the combination of pembrolizumab with bevacizumab and oral cyclophosphamide is an effective alternative in heavily pre-treated patients with ovarian cancer who have otherwise limited treatment options.

查看译文

关键词

Ovarian Neoplasms

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要